Measuring energy needs in palliative cancer patients
Resting Energy Expenditure in Palliative Cancer Patients (REPAT) - an Explorative Study in Patients With Incurable Cancer
This study is trying to find out how much energy people with incurable cancer need by measuring their resting energy levels and seeing if certain factors affect their metabolism.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Norwegian University of Science and Technology Academic / other |
| Locations | 1 site (Trondheim) |
| Trial ID | NCT06206785 on ClinicalTrials.gov |
What this trial studies
This study aims to measure resting energy expenditure (REE) in patients with incurable cancer using indirect calorimetry. It will assess the accuracy of predictive equations for determining energy requirements and identify clinical factors associated with metabolism variations. Data will be collected from patient journals and REE measurements at a single time point, with ongoing monitoring of survival outcomes. The goal is to enhance understanding of energy needs in this patient population.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a verified diagnosis of an incurable malignant disease who are hospitalized at the Cancer clinic.
Not a fit: Patients with cognitive impairment, those requiring supplementary oxygen, or those receiving invasive or noninvasive ventilation may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved nutritional management and care strategies for palliative cancer patients.
How similar studies have performed: While similar studies on energy expenditure in cancer patients exist, this specific approach focusing on REE measurement in palliative care is less common and may provide novel insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * A verified diagnosis of an incurable malignant disease * Hospitalized at the Cancer clinic, St. Olavs Hospital * ≥ 18 years of age * Able to provide written informed consent * Able to comply with all study procedures Exclusion Criteria: * Cognitive impairment * In need of supplementary oxygen * Receiving invasive or noninvasive ventilation
Where this trial is running
Trondheim
- Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital — Trondheim, Norway (Recruiting)
Study contacts
- Study coordinator: Trude R Balstad, PhD
- Email: trude.r.balstad@ntnu.no
- Phone: +4792282665
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.